Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury. - Wikidata - awgldk - TriplyDB

Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury.

Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury.

http://www.wikidata.org/entity/Q44210996

about

A functional SNP in PSMA6 confers risk of myocardial infarction in the Japanese population Regulation of the proteasome by ATP: implications for ischemic myocardial injury and donor heart preservation The ubiquitin-proteasome system and cardiovascular disease Targeting the ubiquitin-proteasome system in heart disease: the basis for new therapeutic strategies Protein quality control and metabolism: bidirectional control in the heart The ubiquitin proteasome system and myocardial ischemia N-acetylcysteine reduces oxidative stress, nuclear factor‑κB activity and cardiomyocyte apoptosis in heart failure Increased O-GlcNAc levels during reperfusion lead to improved functional recovery and reduced calpain proteolysis MicroRNA-682-mediated downregulation of PTEN in intestinal epithelial cells ameliorates intestinal ischemia-reperfusion injury Dichotomous actions of NF-kappaB signaling pathways in heart.Proteasome inhibitors and cardiac cell growth The ubiquitin-proteasome system in myocardial ischaemia and preconditioning.Proteasomal and lysosomal protein degradation and heart disease.Mechanisms and consequences of injury and repair in older organ transplants Effects of a Proteasome Inhibitor on Cardiomyocytes in a Pressure-Overload Hypertrophy Rat Model: An Animal Study.Oleanolic acid: a novel cardioprotective agent that blunts hyperglycemia-induced contractile dysfunction.Impaired autophagy contributes to adverse cardiac remodeling in acute myocardial infarction.Effects of rosuvastatin on ADMA, rhokinase, NADPH oxidase, caveolin-1, hsp 90 and NFkB levels in a rat model of myocardial ischaemia-reperfusion.The protective effects of the proteasome inhibitor bortezomib (velcade) on ischemia-reperfusion injury in the rat retina.The interplay between autophagy and the ubiquitin-proteasome system in cardiac proteotoxicity Proteome dynamics and proteome function of cardiac 19S proteasomes Comparison of the ventricle muscle proteome between patients with rheumatic heart disease and controls with mitral valve prolapse: HSP 60 may be a specific protein in RHD.Reductions of the components of the calreticulin/calnexin quality-control system by proteasome inhibitors and their relevance in a rodent model of Parkinson's disease.Partial inhibition of the ubiquitin-proteasome system ameliorates cardiac dysfunction following ischemia-reperfusion in the presence of high glucose Activation of Chymotrypsin-Like Activity of the Proteasome during Ischemia Induces Myocardial Dysfunction and Death Inhibitory kappa-B kinase-β inhibition prevents adaptive left ventricular hypertrophy Genetically induced moderate inhibition of the proteasome in cardiomyocytes exacerbates myocardial ischemia-reperfusion injury in mice.The ubiquitin-proteasome pathway in viral infections.Understanding proteasome assembly and regulation: importance to cardiovascular medicine.Contribution of mammalian target of rapamycin in the pathophysiology of cirrhotic cardiomyopathy.Proteasome inhibitors: poisons and remedies.Protein quality control and degradation in cardiomyocytes.Proteasome inhibition decreases cardiac remodeling after initiation of pressure overload Protection of peroxiredoxin II on oxidative stress-induced cardiomyocyte death and apoptosis.Cardiomyocyte-specific p65 NF-κB deletion protects the injured heart by preservation of calcium handling.Gambogic acid suppresses pressure overload cardiac hypertrophy in rats.Build it up-Tear it down: protein quality control in the cardiac sarcomere.Appetite for destruction: E3 ubiquitin-ligase protection in cardiac disease.Proteasome inhibition during myocardial infarction.The E3 ligase Mule protects the heart against oxidative stress and mitochondrial dysfunction through Myc-dependent inactivation of Pgc-1α and Pink1.

P2860

Q24297364-3C7A39FD-8735-4F29-99F5-99223EB27575 Q27000202-58AA5979-0A4C-4EA1-AE92-ABDC5F140F5C Q27021582-AA7FA4EB-74E2-426F-98BF-F92041D90D86 Q27026951-7EB5844F-D300-48E4-87B6-7E8FEA9A658F Q28256472-8A098AC3-3C9B-4714-B6E8-6DA2B1E73115 Q28280898-CA9BA782-BC6E-4BE4-946E-2173CD20555E Q28389987-2BAFC800-0CBA-4FDD-8588-AFE820869D4D Q28568343-C5DEAC23-6A01-4BC9-9A1E-66104B3F2C7E Q28833609-E6967074-262B-4801-88B7-CBCF0F3BF006 Q30390478-7CF8B60F-2184-4B35-8D16-DDA0A764E2AA Q33554490-A1558F9A-53A1-4CF9-B548-AC7965C5BC23 Q33554506-3262DDBD-EFE8-4726-8782-2FA9DCB82650 Q33573707-A26FA9BC-C316-4B92-B0D5-0C8FE44FB0CC Q33700247-27B89686-B97E-4D3A-A9AD-EB90BE6A6874 Q33769449-CEB6FCDF-F57C-4855-9C53-DC029A453A71 Q34455196-34D9F1E7-AE3D-40D9-8FE9-A80550014A76 Q34542224-3D0924DD-C319-4B62-8CDF-0698DD333C0D Q34562019-EFB99FD1-011C-4ABB-B0A7-957570A7BCB3 Q34731408-5E511A3D-B0EE-449C-AF52-FF641A2E6B11 Q34778984-7B02B89D-F450-4DB4-8025-AB33C0B96A0D Q34994354-CA41C85A-B4BB-4729-BA74-F6227169F23C Q35149916-D34FD84D-C9FB-43F0-BFE7-9961530BF947 Q35547344-E567F869-5067-4EA7-ADEE-604BFA87EB3A Q35896759-1C4F0D77-F3F2-40F9-8955-8B64B3F7BBCD Q36104970-1BA9A8A7-D905-453D-B2B6-F261A72574FC Q36110312-39AB504A-64B1-44B9-BB42-88CBCDEAFE30 Q36184878-BCEBA2D9-6542-487E-B133-BD688A414374 Q36538328-53968291-5161-41B2-AF78-3884D3CAE002 Q36740475-14A808C5-5F2C-4E1E-A81F-DA7D740EAB49 Q36909237-71DFAAC9-6EA9-404A-A8CD-E2AC2FF593AD Q36945797-87B44EE8-31B0-4A76-B070-0200DBF3A67A Q36952213-8E9FCD04-1C56-475F-B625-4C5101155461 Q36995160-8690F3AA-16A7-4262-847D-15D9A06C5EE9 Q37219497-8A88649A-3967-4910-B425-8D1769470BA2 Q37234808-128EF38D-9924-4B6A-BD48-80B68091242A Q37285392-C5400086-C764-426D-A0A4-E6EBF3143FEA Q37313697-3685C34E-1AA3-4C78-A3A3-6E8CB708DC54 Q37526448-70BB34BF-A901-4ACC-8C0D-737BD295FDDA Q37595119-6A7E31E9-411A-462D-81CF-4A1730606515 Q37620424-11FD24AB-DC3E-4B86-AB6C-4717EBA1EFDC

P2860

Proteasome inhibition ablates activation of NF-kappa B in myocardial reperfusion and reduces reperfusion injury.

http://www.wikidata.org/entity/Q44210996

description

2002 nî lūn-bûn

@nan

2002年の論文

@ja

2002年学术文章

@wuu

2002年学术文章

@zh

2002年学术文章

@zh-cn

2002年学术文章

@zh-hans

2002年学术文章

@zh-my

2002年学术文章

@zh-sg

2002年學術文章

@yue

2002年學術文章

@zh-hant

name

Proteasome inhibition ablates ...... nd reduces reperfusion injury.

@en

Proteasome inhibition ablates ...... nd reduces reperfusion injury.

@nl

type

label

Proteasome inhibition ablates ...... nd reduces reperfusion injury.

@en

Proteasome inhibition ablates ...... nd reduces reperfusion injury.

@nl

prefLabel

Proteasome inhibition ablates ...... nd reduces reperfusion injury.

@en

Proteasome inhibition ablates ...... nd reduces reperfusion injury.

@nl

P1433

Q44210996-39547B96-7617-4578-BB02-25E6A4498055

P1476

Q44210996-91F3EC32-1119-4E6D-98B9-747B8CF70E90

P2093

Q44210996-0D3878C6-6F49-477E-B33E-4C34DB213B9C

Q44210996-2CC40382-530F-4F49-8686-A5489DFB49AA

Q44210996-30E34640-39CD-422C-A516-03600A01C2A7

Q44210996-4157639C-F278-43F1-A702-5C8F5334D50E

Q44210996-46592488-68D0-413D-ABD0-0424A4488B70

Q44210996-7DC21D8A-DDE8-44BB-BFE1-C01E205708E6

Q44210996-89E4A855-E6E6-4735-B825-1134BB839F32

Q44210996-ADC20BCC-8F8A-4687-B99E-BEB3389598F9

Q44210996-B8587E96-4235-420B-A381-63766D448829

Q44210996-C4F1679A-28C2-4BBE-B3A4-25E6AF443C3F

P2860

Q44210996-043F606C-7B8F-4D95-9B78-209500E43A0A

Q44210996-0D8209E9-A9F3-4EB9-AA6D-4C34E08576FA

Q44210996-0EF72F28-29C6-49F6-8778-B1E8E205E948

Q44210996-36374B65-D66C-40C4-9D96-30B2CD74C524

Q44210996-52949573-838B-4AC7-85A8-EB991E5B300E

Q44210996-58DC7A0C-A3C5-4751-964B-0F4C020D115F

Q44210996-8EC79074-9181-45A0-953C-96493ACB3ABC

Q44210996-911CF2D3-A694-46C0-8646-6CE3140E4961

Q44210996-91923D6C-77C0-4CBC-ACAE-2621BE46B6BD

Q44210996-A8973D15-DE4C-4F06-A002-6987197E4FE0

P304

Q44210996-9421A546-DD4F-4886-9FEF-31D5E6D34D64

P31

Q44210996-F20118B5-F9A4-4F19-A6D5-ED740B224EEF

P356

Q44210996-04BB07F4-9E1F-4FDA-BF44-629B404A8A82

P433

Q44210996-6EABA78D-2D75-4D71-902B-6541734C7676

P478

Q44210996-32F2E7E6-201B-48E5-8F7A-2F9DC22CF168

P577

Q44210996-AB433508-0C5F-4F57-A3DF-5FCC6F8402B7

P5875

Q44210996-A88195D6-7D17-48A3-99A5-BD91613CF45B

P698

Q44210996-729A3020-6E1E-4D45-8CB4-7D5E734286D8

P921

Q44210996-5BB16D16-3759-4936-981C-0A0CCC574064

P356

AJPHEART.00851.2002

P1433

American Journal of Physiology - Heart and Circulatory Physiology

P1476

Proteasome inhibition ablates ...... nd reduces reperfusion injury.

@en

P2093

Albert S Baldwin

http://www.w3.org/2001/XMLSchema#string

Arlene McCain

http://www.w3.org/2001/XMLSchema#string

Christine Pien

http://www.w3.org/2001/XMLSchema#string

Dwight A Bellinger

http://www.w3.org/2001/XMLSchema#string

Elizabeth Merricks

http://www.w3.org/2001/XMLSchema#string

Farhad Ardeshirpour

http://www.w3.org/2001/XMLSchema#string

Joseph Pye

http://www.w3.org/2001/XMLSchema#string

Julian Adams

http://www.w3.org/2001/XMLSchema#string

Peter J Elliott

http://www.w3.org/2001/XMLSchema#string

Thomas H Fischer

http://www.w3.org/2001/XMLSchema#string

P2860

The NF-kappa B and I kappa B proteins: new discoveries and insights

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

Synergistic activation of NF-kappaB by tumor necrosis factor alpha and gamma interferon via enhanced I kappaB alpha degradation and de novo I kappaBbeta degradation

Characterization of an immediate-early gene induced in adherent monocytes that encodes I kappa B-like activity

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

Molecular and cellular mechanisms of myocardial stunning.

Bridging the gap: composition, regulation, and physiological function of the IkappaB kinase complex.

Transcriptional activation by NF-kappaB requires multiple coactivators

Series introduction: the transcription factor NF-kappaB and human disease

Welcome to the machine: a cardiologist's introduction to protein folding and degradation.

P304

H919-26

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPHEART.00851.2002

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

284

http://www.w3.org/2001/XMLSchema#string

P577

2002-11-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11042709

http://www.w3.org/2001/XMLSchema#string

P698

12424098

http://www.w3.org/2001/XMLSchema#string

P921

reperfusion injury